We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cranial Accelerometry Headset Enables Timely and Accurate Prehospital Detection of LVO Strokes

By HospiMedica International staff writers
Posted on 22 Nov 2024

Large-vessel occlusion (LVO) strokes account for one-third of acute ischemic stroke (AIS) cases in the United States and are responsible for two-thirds of poststroke disability and 90% of stroke-related mortality. More...

The introduction of endovascular thrombectomy (EVT) has significantly improved the management of LVO strokes in recent years, underscoring the critical need for quick identification and transport to hospitals capable of performing EVT. Despite these advancements, accurate prehospital detection of LVO strokes remains a major challenge. A new study now explores the feasibility of using cranial accelerometry (CA) headsets to detect LVO strokes in the prehospital setting.

In the EPISODE-PS-COVID study, researchers from Wayne State University School of Medicine (WSUSOM, Detroit, MI, USA) evaluated the feasibility of MindRhythm’s (Cupertino, CA, USA) Harmony 5000 CA headset for identifying LVO stroke in prehospital suspected stroke patients. CA technology works by detecting cranial forces generated by cardiac contractions to identify patterns indicative of LVO strokes. The Harmony 5000 device, a headband with three leads and a handheld screen, has already demonstrated high sensitivity and specificity in emergency department and neuro-interventional settings.

The study enrolled 594 participants, including 183 who used the second-generation device. Usable data were obtained from 158 patients (86.3%). The cohort was 53% female and 56% Black/African American, with a median age of 69 years. Of the participants, 26 (16.4%) had LVO strokes, while 132 (83.6%) did not (33 with non-LVO AIS, nine with intracerebral hemorrhage, and 90 with stroke mimics). The study also reported no significant differences in COVID-19 positivity rates between the groups (10.6%). The researchers found a sensitivity of 38.5% and specificity of 82.7% for the LAMS ≥ 4 method in detecting LVO strokes, compared to a sensitivity of 84.6% (p < 0.0015 for superiority) and specificity of 82.6% (p = 0.81 for superiority) for the device’s CA + LAMS algorithm. Published in Academic Emergency Medicine, these findings demonstrate that using the CA device to capture adequate data in prehospital settings is feasible, marking a significant step forward in stroke management.

“The EPISODE-PS-COVID study is, to our knowledge, the first to evaluate the use of a cranial accelerometry device for LVO stroke detection in prehospital settings,” said James H. Paxton, MD, MBA, from the Department of Emergency Medicine at WSUSOM who led the study.

Related Links:
WSUSOM
MindRhythm


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Glucose Meter
StatStrip®
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.